Many physicians treating hemodialysis (HD) patients seem not to be aware of the possibility that their patients might also suffer from hepatitis C (HCV).
Figures show that the disease is only rarely treated, warns a team of US-American, Belgian and Japanese researchers (Goodkin DA et al, Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis; Clin J Am Soc Nephrol 2017;12:287-297).
The present prospective cohort study should serve as an eye-opener. Among the study cohort, HCV had a prevalence of 7.5 % and was associated with a higher risk of death and hospitalization and a worse quality of life. However, only 1.5 % of HCV-positive patients in this study received adequate anti-HCV treatment.